Concepedia

Alexandr Belovodskiy

AB

Statistics

Publications

5

Citations

348

H-Index

5

Active since

2017

Affiliations

University of Alberta(Current)

Alexandr Belovodskiy is an author at University of Alberta specializing in drug discovery, peptidomimetic design, and pharmacology.

ORCID

Publications per year

2017–2021

5

Publications

5

Comprehensive in vitro characterization of PD-L1 small molecule inhibitors

Aravindhan Ganesan, Marawan Ahmed, Isobel Okoye et al. · Scientific Reports · 2019 · 134 citations · Full text

, , +17

Peptidomimetic α-Acyloxymethylketone Warheads with Six-Membered Lactam P1 Glutamine Mimic: SARS-CoV-2 3CL Protease Inhibition, Coronavirus Antiviral Activity, and <i>in Vitro</i> Biological Stability

Bing Bai, Alexandr Belovodskiy, Mostofa Abu Hena et al. · Journal of Medicinal Chemistry · 2021 · 107 citations · Full text

, , +17

Peptidomimetic nitrile warheads as SARS-CoV-2 3CL protease inhibitors

Bing Bai, Elena Arutyunova, Muhammad Bashir Khan et al. · RSC Medicinal Chemistry · 2021 · 60 citations · Full text

, , +15

Establishing normal metabolism and differentiation in hepatocellular carcinoma cells by culturing in adult human serum

Rineke Steenbergen, Martin Oti, Rob ter Horst et al. · Scientific Reports · 2018 · 29 citations · Full text

, , +17

Fluorescent Hexose Conjugates Establish Stringent Stereochemical Requirement by GLUT5 for Recognition and Transport of Monosaccharides

Mohamad Soueidan, Thomas W. Scully, Jatinder Kaur et al. · ACS Chemical Biology · 2017 · 18 citations

, , +17

1–5 of 5